PTCT logo

PTCT

PTC Therapeutics Inc.

$49.33
-$0.46(-0.92%)
56
Overall
60
Value
60
Tech
50
Quality
Market Cap
$3.93B
Volume
906.92K
52W Range
$30.41 - $58.38
Target Price
$66.69
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$36.8M$82.7M$194.4M$264.7M$307.0M$380.8M$538.6M$698.8M$937.8M$806.8M
Total Revenue
$33.7M$81.4M$194.4M$264.7M$307.0M$380.8M$538.6M$698.8M$937.8M$806.8M
COST OF GOODS SOLD
Cost of Revenue
----$-4.6M$-12.7M$400.0K$18.9M$32.3M$44.7M$65.5M$57.4M
GROSS PROFIT
Gross Profit
$36.8M$82.7M$-4.6M$-12.7M$307.0M$361.8M$506.3M$654.1M$937.8M$749.4M
OPERATING EXPENSES
Operating Expenses
$-203.9M$-214.8M$-258.7M$-380.4M$548.1M$812.5M$913.0M$1.1B$1.4B$1.1B
Research & Development
$121.8M$117.6M$117.5M$172.0M$257.5M$477.6M$540.7M$651.5M$666.6M$534.5M
Research Expense
$121.8M$117.6M$117.5M$172.0M$257.5M$477.6M$540.7M$651.5M$666.6M$534.5M
Selling, General & Administrative
$82.1M$97.1M$121.3M$153.5M$202.5M$245.2M$285.8M$326.0M$332.5M$300.9M
Selling & Marketing Expenses
----$121.3M$153.5M$202.5M$245.2M$285.8M------
General & Administrative Expenses
$82.1M$97.1M$-2.2M$-2.7M$202.5M$245.2M$285.8M$326.0M$332.5M$300.9M
Salaries & Wages
$-34.0M$-35.0M$-30.6M$-33.3M$-42.1M$-70.3M$-103.5M------
Depreciation & Amortization
$-2.9M$-3.3M$15.4M$22.9M$27.6M$36.9M$54.8M$116.6M$222.6M$60.7M
Depreciation & Amortization
$-2.9M$-3.3M$15.4M$22.9M$27.6M$36.9M$54.8M$116.6M$222.6M$60.7M
Amortization
$-107.0K$-302.0K$15.4M$22.9M$27.6M$36.9M$54.8M$116.6M$222.6M$60.7M
Other Operating Expenses
$-203.9M$-214.8M$-258.7M$-380.4M$-12.1M$-29.6M$-32.3M$-44.7M----
OPERATING INCOME
Operating income
$-167.1M$-132.1M$-258.7M$-361.1M$-241.2M$-431.8M$-374.4M$-447.4M$-439.5M$-302.6M
EBITDA
$-164.5M$-136.1M$-59.0M$-101.9M$-205.3M$-303.1M$-368.2M$-356.0M$-447.8M$-278.5M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------$56.4M$86.0M$90.9M$129.2M--
Intinc
$-2.4M$-8.3M$-12.1M$-12.6M$-12.5M$-56.4M$-86.0M$-90.9M$-129.2M$-167.0M
Net Non-Operating Interest Income/Expense
$-2.4M$-8.3M$-12.1M$-12.6M$-12.5M$-56.4M$-86.0M$-90.9M$-129.2M$-167.0M
Gain on Sale of Securities
--------$2.2M$700.0K$800.0K$4.0M----
Other Income/Expense
$465.0K$1.2M$-193.1M$-245.5M$34.6M$-61.9M$57.4M$-56.7M$217.5M$148.5M
Other Special Charges
$-465.0K$-1.2M$193.1M$264.9M$13.7M$85.2M$-57.9M$-49.2M$-127.4M$6.5M
SPECIAL ITEMS
Special Income Charges
----$6.8M$7.5M------------
Other Impairment Of Capital Assets
--------------$33.4M$217.8M$159.5M
PRE-TAX INCOME
EBIT
$-170.0M$-141.5M$-77.7M$-128.1M$-239.9M$-346.6M$-432.3M$-496.6M$-696.1M$-363.1M
Pre-Tax Income
$-170.0M$-141.5M$-77.7M$-128.1M$-239.9M$-402.9M$-518.3M$-587.5M$-696.1M$-363.1M
INCOME TAX
Tax Provision
$485.0K$569.0K$1.3M$-29.0K$11.7M$35.2M$5.6M$-28.5M$-69.5M$176.0K
NET INCOME
Net Income
$-170.4M$-142.1M$-79.0M$-128.1M$-251.6M$-438.2M$-523.9M$-559.0M$-626.6M$-363.3M
Net Income (Continuing Operations)
$-170.4M$-142.1M$-79.0M$-128.1M$-251.6M$-438.2M$-523.9M$-559.0M$-626.6M$-363.3M
Net Income (Discontinued Operations)
$-170.4M$-142.1M$-79.0M$-128.1M$-251.6M$-438.2M$-523.9M$-559.0M$-626.6M$-363.3M
Net Income (Common Stockholders)
$-170.4M$-142.1M$-79.0M$-128.1M$-227.3M$-379.1M$-459.2M$-559.0M$-626.6M$-363.3M
TOTALS
Total Expenses
$-203.9M$-214.8M$-263.3M$-393.1M$548.5M$813.0M$915.2M$1.1B$1.4B$1.2B
SHARE & EPS DATA
Average Shares Outstanding
$33.6M$34.0M$39.2M$46.6M$58.9M$66.0M$70.5M$71.7M$74.8M$76.8M
Average Shares Outstanding (Diluted)
$33.6M$34.1M$39.1M$46.6M$58.9M$66.0M$70.5M$71.7M$74.8M$76.8M
Shares Outstanding
$34.3M$34.6M$41.8M$58.4M$62.6M$70.3M$71.4M$73.8M$76.6M$78.9M
Basic EPS
------$-2.75$-4.27--$-7.43$-7.79$-8.37$-4.73
Basic EPS (Continuing Operations)
--------------$-7.79$-8.37$-4.73
Diluted EPS
$-5.07$-4.17$-2.02$-2.75$-4.27$-6.64$-7.43$-7.79$-8.37$-4.73
Diluted EPS (Continuing Operations)
--------------$-7.79$-8.37$-4.73
OTHER METRICS
Gain On Sale Of P P E
----$-5.0K$-2.0K------------
Other Gand A
$82.1M$97.1M$-2.2M$-2.7M$202.5M$245.2M$285.8M$326.0M$332.5M$300.9M
Rent And Landing Fees
$82.1M$97.1M$121.3M--------------
Selling Expense
----$121.3M$153.5M$202.5M$245.2M$285.8M------
Othspecchg
----$-6.8M$-7.5M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2PTCT$49.33-0.9%906.92K
3
4
5
6

Get PTC Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.